StratGraph
Companies / Health Care
HSIC

Henry Schein

Health Care Distributors

Health Care DistributorsAnalysis in progress
In progress

We are decoding this company's strategy and relationships

New analyses are published every weekday. Founding members get them first.

Business at a glance

Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work

Operating health53
Growth34
Profitability28
Cash generation59
Balance sheet47
Dilution control100
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-26)4.0%Revenue growth (FY)4.0%Revenue CAGR (3y)1.4%Gross margin31.1%Operating margin5.0%Net margin3.0%Free cash flow margin4.3%R&D / revenue—Stock comp / revenue0.3%Net debt / operating cash flow4.10xCurrent ratio1.38Diluted share count change-4.7%
Fiscal year endingFY 2021-12FY 2022-12FY 2023-12FY 2024-12FY 2025-12
Revenue$12.4B$12.6B$12.3B$12.7B$13.2B
Gross profit$3.7B$3.8B$3.9B$4.0B$4.1B
Operating income$852M$747M$615M$621M$653M
Net income$631M$538M$416M$390M$398M
Operating cash flow$710M$602M$500M$848M$712M
Capital expenditure$79M$96M$147M$148M$139M
Free cash flow$631M$506M$353M$700M$573M
Stock-based comp$78M$54M$39M$39M$39M
Buybacks$401M$485M$250M$385M$850M
Cash$118M$117M$171M$122M$156M
Total debt$873M$1.1B$2.2B$2.5B$3.1B
Equity$3.4B$3.4B$3.7B$3.4B$3.2B

StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.